In our study, we found significantly higher rates of anti‐cardiolipin IgM antibody and anti‐cardiolipin IgG antibody positivity in LN patients with thrombocytopenia, aligning with the findings of previously published studies. This evidence concerns the gene CD40LG and Thrombocytopenia.